Researchers have been investigating the physical and morphological properties of biodegradable polymer and copolymer films, blending them with other chemicals to solve challenges in medical, industrial, and eco-environmental fields. The present study introduces a novel, straightforward method for preparing biodegradable hydrogels based on polyvinyl alcohol (PVA) and polyvinyl pyrrolidone (PVP) for medical applications. The resulting PVA/PVP-based hydrogel uniquely combines the water absorbency, biocompatibility, and biodegradability of the polymer composite. For hygiene products and medical uses, such as wound healing, hydrogen peroxide (HP) was encapsulated in the PVA/PVP hydrogels for controlled release application. Incorporating PVP into PVA significantly enhances the hydrogel water absorbency and improves the mechanical properties. However, to mitigate the disadvantage of high water absorbency which could result in undesired early dissolution, efforts were made to increase the water resistance and the mechanical characteristics of these hydrogels using freeze–thaw (F/T) cycles and chemical crosslinking PVA chains with trisodium trimetaphosphate (STMP). The resulting hydrogels serve as environmentally friendly bio-based polymer blends, broadening their applications in medical and industrial products. The structural and morphological properties of the hydrogel were characterized using Fourier transform infrared spectroscopy (FTIR), environmental scanning electron microscope analysis (E-SEM), and water-swelling tests. The HP controlled release rate was evaluated through kinetic release experiments using the ex vivo skin model. The antibacterial activity of the hydrogel films was examined on four medically relevant bacteria: Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa, with an adapted disk diffusion assay. Using this assay, we also evaluated the antibacterial effect of the hydrogel films over the course of days, demonstrating the HP controlled release from these hydrogels. These findings support further in vivo investigation into controlled HP release systems for improved wound-healing outcomes.
Prophages are bacteriophages in the lysogenic state, where the viral genome is inserted within the bacterial chromosome. They contribute to strain genetic variability and can influence bacterial phenotypes. Prophages are highly abundant among the strains of the opportunistic pathogen Pseudomonas aeruginosa and were shown to confer specific traits that can promote strain pathogenicity. The main difficulty of studying those regions is the lack of a simple prophage-curing method for P. aeruginosa strains. In this study, we developed a novel, targeted-curing approach for prophages in P. aeruginosa. In the first step, we tagged the prophage for curing with an ampicillin resistance cassette (ampR) and further used this strain for the sacB counter-selection marker’s temporal insertion into the prophage region. The sucrose counter-selection resulted in different variants when the prophage-cured mutant is the sole variant that lost the ampR cassette. Next, we validated the targeted-curing with local PCR amplification and Whole Genome Sequencing. The application of the strategy resulted in high efficiency both for curing the Pf4 prophage of the laboratory wild-type (WT) strain PAO1 and for PR2 prophage from the clinical, hard to genetically manipulate, 39016 strain. We believe this method can support the research and growing interest in prophage biology in P. aeruginosa as well as additional Gram-negative bacteria.
Bacterial biofilms remain a major challenge in clinical infections due to their dense extracellular polymeric substance (EPS) matrix and strong resistance to conventional antibiotics. This study reports manganese dioxide (MnO2) nanoparticles capable of autonomous navigation toward bacterial clusters, mechanical penetration of biofilm structures, redox-driven membrane disruption, and synergistic oxidative stress. The nanoparticles exhibit directional movement attributed to a combination of negatively charged surface potential, asymmetric topology, and catalytic reactivity toward bacterial metabolites. MnO2 demonstrates potent antibiofilm activity against MRSA and MDR E. coli (>98% eradication) and partial activity against Pseudomonas aeruginosa. Time-lapse microscopy, EPR spectroscopy, XPS analysis, and SEM imaging reveal that MnO2 disrupts both EPS and cell membranes while maintaining structural integrity throughout treatment. Cytotoxicity assays confirm ≥85% viability in human fibroblasts and keratinocytes at therapeutic concentrations. MnO2 shows controlled biodegradation into Mn2+ ions, which participate in physiological pathways and undergo renal clearance. These findings support MnO2 nanoparticles as promising biofilm-targeting agents for topical formulations, wound care, and implant coatings.
We present here a one-pot hydrothermal synthesis of fluorescent carbon dots (CDs) using olive, rosemary, sage, and thyme leaves as a carbon source. The hydrothermal reaction was conducted at 180 °C for 12 h, thereby converting biomass into water-dispersible CDs without a passivating agent. The average size of the CDs, determined by TEM, was 3–6 nm, with a spherical morphology. All synthesized CDs displayed excitation-dependent fluorescence, with emission maxima at 400–440 nm (blue) with excitation at 340–370 nm. FLIM measurements yielded similar fluorescence lifetimes of approximately 5 ns in aqueous solutions of CDs. FTIR spectra indicated surface hydroxyl and nitrogen-containing functionalities that may contribute to photoluminescence. The antibacterial activity of the as-synthesized CDs against a panel of Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Listeria innocua, Escherichia coli, Pseudomonas aeruginosa, methicillin-resistant S. aureus (MRSA), multidrug-resistant (MDR) E. coli, and Klebsiella pneumoniae (MDR)) was investigated. It was shown that biomass-derived CDs exhibit antibacterial activity, being more effective against Gram-positive bacteria, with MIC values as low as 0.625 mg/mL for olive-, rosemary-, and thyme-derived CDs against S. aureus and MRSA. These findings suggest that the developed CDs are fluorescent materials offering viable possibilities in biomedical research, as well as antimicrobial agents.